Alopecia Universalis: An Extremely Rare but Probable Adverse Effect of Adalimumab
January 2014
in “
IOSR journal of pharmacy
”
Studysummary This case report identifies alopecia universalis as a probable adverse drug reaction to adalimumab in a patient with psoriasis and psoriatic arthritis.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on doi.org →